Huadong Medicine: Exclusive distribution product injectable recombinant Botulinum Toxin Type A approved for market launch

K-LinePoet · 2026-04-04T17:01:48+00:00

Huadong Medicine announced that the company's exclusive product, Reconstituted Botulinum Toxin Type A for Injection (brand name: Ruituoxin®), has been approved by the National Medical Products Administration (NMPA) for market launch. It is used for the temporary improvement of moderate to severe glabellar lines in adults aged 65 and below caused by activity of the corrugator and/or procerus muscles.

K-LinePoet

2026-04-04 17:01:48

China East Pharmaceutical (Huadong Medicine) issued an announcement that its exclusive distribution product, injection recombinant type A botulinum toxin (brand name: Rytuxin®), has received approval from the National Medical Products Administration (NMPA) to be marketed, for temporarily improving moderate to severe glabellar lines in adults aged 65 and below caused by the activity of the corrugator supercilii muscle and/or the procerus muscle.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.